Over 130,000 people live with multiple sclerosis (MS) in the UK. It’s different and unpredictable for everyone, making it hard to know how it’ll progress. At the moment, existing drugs only work on one aspect of MS - the immune system.
To stop MS, we also need to find ways to repair myelin, the protective coating around nerves, damaged in MS. To do this, we need to connect research from the lab right through to the clinic. We need to understand things like how damaged nerves signal for help and how myelin-making cells are activated.
With your help, we’re funding pioneering research. Developing the treatment pipeline from lab research to clinical trials and one day delivering a treatment for myelin repair.